CARsgen Therapeutics Holdings (HKSE:02171) EPS (Basic) : HK$-1.35 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CARsgen Therapeutics Holdings EPS (Basic)?

CARsgen Therapeutics Holdings's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was HK$-0.68. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-1.35.

CARsgen Therapeutics Holdings's EPS (Diluted) for the six months ended in Jun. 2024 was HK$-0.68. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-1.35.

CARsgen Therapeutics Holdings's EPS without NRI for the six months ended in Jun. 2024 was HK$-0.68. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -1.35.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

CARsgen Therapeutics Holdings EPS (Basic) Historical Data

The historical data trend for CARsgen Therapeutics Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings EPS (Basic) Chart

CARsgen Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.52

-2.22

-15.01

-1.81

-1.47

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial					-0.81	-1.04	-0.80	-0.67	-0.68

CARsgen Therapeutics Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CARsgen Therapeutics Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-817.921	-	0)	/	558.055
	=	-1.47

CARsgen Therapeutics Holdings's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-378.467	-	0)	/	557.030
	=	-0.68

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.35

CARsgen Therapeutics Holdings (HKSE:02171) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CARsgen Therapeutics Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (HKSE:02171) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN

Website

https://www.carsgen.com

CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.

Executives

Guo Bingsen	2401 A concert party to an agreement to buy shares
Guo Huaqing	2101 Beneficial owner
Li Zonghai	2401 A concert party to an agreement to buy shares
Wang Huamao	2401 A concert party to an agreement to buy shares
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Gic Private Limited	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Yang Zhi	2201 Interest of corporation controlled by you
Prowell Ventures Pte Ltd	2201 Interest of corporation controlled by you
Bvcf Realization Fund, L.p.	2201 Interest of corporation controlled by you
Bvcf Realization Fund Gp, Ltd.	2201 Interest of corporation controlled by you
Zhejiang Jolly Healthcare Investment Management Limited	2201 Interest of corporation controlled by you
Applied Biomaterial Ltd.	2201 Interest of corporation controlled by you
Zhejiang Jolly Pharmaceutical Co., Ltd.	2201 Interest of corporation controlled by you
Zhejiang Zuoli Innovation Medical Investment Management Co., Ltd.	2101 Beneficial owner

CARsgen Therapeutics Holdings Headlines

No Headlines